400 related articles for article (PubMed ID: 19479974)
1. Mucinous gastric carcinomas: clinicopathologic and molecular analyses.
Choi JS; Kim MA; Lee HE; Lee HS; Kim WH
Cancer; 2009 Aug; 115(15):3581-90. PubMed ID: 19479974
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic study of early-stage mucinous gastric carcinoma.
Adachi Y; Yasuda K; Inomata M; Shiraishi N; Kitano S; Sugimachi K
Cancer; 2001 Feb; 91(4):698-703. PubMed ID: 11241236
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic characteristics and prognosis of mucinous gastric carcinoma.
Zhang M; Zhu GY; Zhang HF; Gao HY; Han XF; Xue YW
J Surg Oncol; 2010 Jul; 102(1):64-7. PubMed ID: 20578080
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
Ann Surg Oncol; 2006 Jun; 13(6):836-42. PubMed ID: 16604474
[TBL] [Abstract][Full Text] [Related]
5. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type.
Adachi Y; Yasuda K; Inomata M; Sato K; Shiraishi N; Kitano S
Cancer; 2000 Oct; 89(7):1418-24. PubMed ID: 11013353
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathology and prognosis of mucinous gastric carcinoma.
Hidaka S; Tanaka K; Takeshita H; Sumida Y; Fukuoka H; Abo T; Yano H; Nanashima A; Sawai T; Yasutake T; Nagayasu T
Hepatogastroenterology; 2008; 55(82-83):791-4. PubMed ID: 18613456
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic characteristics of mucinous gastric adenocarcinoma.
Hyung WJ; Noh SH; Shin DW; Yoo CH; Kim CB; Min JS; Lee KS
Yonsei Med J; 1999 Apr; 40(2):99-106. PubMed ID: 10333711
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China.
Song W; Wu SJ; He YL; Cai SR; Zhang CH; Zhang XH; Zhan WH
Chin Med J (Engl); 2009 Jul; 122(13):1486-91. PubMed ID: 19719934
[TBL] [Abstract][Full Text] [Related]
9. Tumor size predicts survival in mucinous gastric carcinoma.
Sung CO; Lee SM; Choi JS; Kim KM; Choi MG; Noh JH; Sohn TS; Bae JM; Kim WH; Park CK; Kim S
J Surg Oncol; 2012 Nov; 106(6):757-64. PubMed ID: 22535583
[TBL] [Abstract][Full Text] [Related]
10. Expression of MUC1 and MUC2 mucins in gastric carcinomas: their relationship with clinicopathologic parameters and prognosis.
Akyürek N; Akyol G; Dursun A; Yamaç D; Günel N
Pathol Res Pract; 2002; 198(10):665-74. PubMed ID: 12498221
[TBL] [Abstract][Full Text] [Related]
11. Mucin core protein expression by colorectal mucinous carcinomas with or without mucus hyperplasia.
Ishizu H; Kumagai J; Eishi Y; Takizawa T; Koike M
J Gastroenterol; 2004; 39(2):125-32. PubMed ID: 15069618
[TBL] [Abstract][Full Text] [Related]
12. c-MYC amplification in mucinous gastric carcinoma: a possible genetic alteration leading to deeply invasive tumors.
Choi JS; Seo J; Jung EJ; Kim EJ; Lee GK; Kim WH
Anticancer Res; 2012 Nov; 32(11):5031-7. PubMed ID: 23155275
[TBL] [Abstract][Full Text] [Related]
13. Role of MUC1 and MUC5AC expressions as prognostic indicators in gastric carcinomas.
Wang JY; Chang CT; Hsieh JS; Lee LW; Huang TJ; Chai CY; Lin SR
J Surg Oncol; 2003 Aug; 83(4):253-60. PubMed ID: 12884239
[TBL] [Abstract][Full Text] [Related]
14. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic and protein expression differences between cardia carcinoma and noncardia carcinoma of the stomach.
Kim MA; Lee HS; Yang HK; Kim WH
Cancer; 2005 Apr; 103(7):1439-46. PubMed ID: 15726543
[TBL] [Abstract][Full Text] [Related]
16. The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays.
Li XH; Zheng HC; Wang ZG; Takahashi H; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(2A):1061-7. PubMed ID: 18507055
[TBL] [Abstract][Full Text] [Related]
17. Micropapillary carcinoma of stomach: a clinicopathologic and immunohistochemical study of 11 cases.
Roh JH; Srivastava A; Lauwers GY; An J; Jang KT; Park CK; Sohn TS; Kim S; Kim KM
Am J Surg Pathol; 2010 Aug; 34(8):1139-46. PubMed ID: 20661012
[TBL] [Abstract][Full Text] [Related]
18. How do gastric carcinoma classification systems relate to mucin expression patterns? An immunohistochemical analysis in a series of advanced gastric carcinomas.
Gürbüz Y; Kahlke V; Klöppel G
Virchows Arch; 2002 May; 440(5):505-11. PubMed ID: 12021925
[TBL] [Abstract][Full Text] [Related]
19. Minute gastric carcinoma of differentiated type with special reference to the significance of intestinal metaplasia, proliferative zone, and p53 protein during tumor development.
Sasaki I; Yao T; Nawata H; Tsuneyoshi M
Cancer; 1999 Apr; 85(8):1719-29. PubMed ID: 10223565
[TBL] [Abstract][Full Text] [Related]
20. Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour.
Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
Histopathology; 2006 Jul; 49(1):35-44. PubMed ID: 16842244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
